Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Alkem Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 1,948.20 81.45  | 4.36% -5.80% 28.75 23,284.09
NSE Price: Sep 20, 15:44 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 20, 15:44 1,948.20 81.45 4.36% 1,885.00 1,866.75 101,998 1,865.00 - 1,974.40
BSE Sep 20, 2019 1,947.40 81.25 4.35% 1,867.55 1,866.15 1,794 1,866.15 - 1,965.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue7,547.657,357.196,391.845,687.534,924.84 3,743.353,126.00
Other Income78.5087.70115.42112.01239.71 181.04165.35
Total Income7,626.157,444.896,507.265,799.545,164.55 3,924.393,291.35
Total Expenditure6,372.196,242.425,382.924,688.584,071.59 3,321.522,716.05
Operating Profit1,253.961,202.471,124.341,110.961,092.96 602.87575.30
Interest54.4954.6355.3345.1671.24 81.1193.08
PBDT1,199.471,147.841,069.011,065.801,021.72 521.76482.22
Depreciation206.56193.18143.03101.1793.31 70.9452.26
PBT & Exceptional Items992.91954.66925.98964.63928.41 450.82429.96
Exceptional Items0.00---- --
Profit before Tax992.91954.66925.98964.63928.41 450.82429.96
Provision for Tax169.25181.02287.5659.96176.18 59.23-5.36
Profit after Tax823.66773.64638.42904.67752.23 391.59435.32
Minority Interest-13.83-13.13-7.48-12.64-10.64 --
Share of Associate0.00---- --
Consolidated Profit809.83760.51630.94892.03741.59 391.59435.32
 
LiabilitiesR Cr
Share Capital23.9123.9123.9123.9123.91 23.9111.96
Total Reserves5,415.435,413.934,838.874,443.343,668.03 2,978.722,573.01
Shareholder's Funds5,439.345,439.344,863.774,467.643,691.96 3,002.632,584.97
Minority Interest132.61132.61121.55115.2395.02 85.65-
Long Term Borrowings231.30231.30130.73181.56123.46 33.43232.25
Other Non Current Liabilities214.72214.42164.60113.4685.61 163.5991.67
Current Liabilities2,190.222,190.222,383.311,689.691,537.60 2,005.981,402.58
Total Debt*-944.07997.56659.46657.50 1,305.921,128.43
Total Liabilities8,208.198,207.897,663.966,567.585,533.65 5,291.284,311.47
 
AssetsR Cr
Net Block2,149.882,530.442,283.591,797.041,449.54 1,374.341,170.01
Non Current Investments95.7495.7498.45259.44234.39 419.73338.24
Other Non-Current Assets1,746.441,365.581,268.701,593.961,081.02 1,159.161,201.08
Current Investments227.88227.88345.82293.56274.18 61.05249.77
Cash and Bank661.60661.60576.78399.26780.90 790.76206.29
Other Current Assets3,326.653,326.653,090.622,224.321,713.62 1,486.241,146.08
Net Current Assets2,025.912,025.911,629.911,227.451,231.10 332.07199.56
Miscellaneous Exp. Not Written Off----- --
Total Assets8,208.198,207.897,663.966,567.585,533.65 5,291.284,311.47
 
Cash FlowR Cr
From Operations-777.41266.04471.14725.83 325.47290.01
From Investing Activities--314.15-357.23-285.93202.27 -236.97350.44
From Finance Activities--378.9484.56-137.88-927.27 -51.78-599.94
Net Inflow/Outflow-84.32-6.6347.330.83 36.7240.51
 
Key Ratios
Adjusted EPS (Rs)67.7363.6152.7874.6262.03 32.7636.40
Adjusted Book Value (Rs)470.47454.86406.76373.67308.82 251.16216.13
Dividend per Share (Rs)-16.0013.0015.0012.70 4.004.00
Cash Flow per Share (Rs)-65.0322.2539.4160.71 27.22242.48
Debt to Equity0.040.170.210.150.18 0.430.44
Current Ratio1.921.921.681.731.80 1.171.14
ROCE (%)-16.4917.8621.3123.09 13.2614.06
RONW (%)15.9915.0213.6922.1822.47 14.0218.28
Operating Margin (%)16.6116.3417.5919.5322.19 16.1118.40
Net Margin (%)10.8010.399.8115.6014.57 9.9813.23
Revenue Growth (%)11.8015.1012.3815.4931.56 19.7525.28
Net Profit Growth (%)15.7021.18-29.4320.2792.10 -10.0513.47
EPS Growth (%)16.4320.54-29.2720.2989.38 -10.0113.42
Book Value Growth (%)-11.838.8521.0022.96 16.1618.72
 
Market Cues
Close Price (Rs)1,948.201,750.851,988.352,204.901,356.45 --
High Price (Rs)2,100.002,268.002,469.002,227.951,588.90 --
Low Price (Rs)1,660.001,690.001,578.301,152.501,227.00 --
Market Cap (Rs Cr)23,284.0920,942.7723,635.0426,384.0916,336.51 0.000.00
Price / Earnings28.7527.5437.4629.5822.03 0.000.00
Price / Book Value4.143.854.865.914.42 0.000.00
Dividend Yield (%)0.820.910.660.680.93 --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
7.86
Piotroski F-Score
8
Modified C-Score
0
3-Years Price to Earnings
28.75
3-Years Price to Book
4.14
Earnings Yield
EBIT / Enterprise value
4.49%
PEG
Price / Earnings to growth ratio
21.62
Related Stocks
  Current Price   Chng %
Abbott India R10,219.15 +3.88%
Biocon R228.05 +0.33%
Cadila Healthcare R247.45 +3.95%
Glaxosmithkline Pharma R1,384.20 -0.82%
Ipca Laboratories R956.10 +0.87%
Lupin R756.30 +2.03%
Pfizer R3,267.85 +0.72%
Sanofi India R5,890.20 +3.91%
Syngene International R317.80 +2.50%
Torrent Pharmaceuticals R1,727.20 +1.47%
As on Sep 20, 15:59